11:23 am Biomarin Pharm receives positive opinion from the CHMP in the EU for VIMIZIM for Morquio A syndrome – HedgeChatter

11:23 am Biomarin Pharm receives positive opinion from the CHMP in the EU for VIMIZIM for Morquio A syndrome

20 Feb

11:23 am Biomarin Pharm receives positive opinion from the CHMP in the EU for VIMIZIM for Morquio A syndrome

Bystocknews BMRN, stock Comments Off

View todays social media effects on BMRN

View the latest stocks trending across Twitter. Click to view dashboard

See who BioMarin is hiring next, click here to view

Author